Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19) | Zendy

Jeffrey D. Jenks | Zendy; Saima Aslam | Zendy; Lucy E. Horton | Zendy; Nancy Law | Zendy; Ajay Bharti | Zendy; Cathy Logan | Zendy; Mahnaz Taremi | Zendy; Florin Vaida | Zendy; Michele Ritter | Zendy; Kathleen Bordeaux | Zendy; Claudia Guerrero | Zendy; Diana Paddock | Zendy; Joseph Bautista | Zendy; Claudia Medrano | Zendy; Sarah Arend | Zendy; Mackenzie Williams | Zendy; Marvin Ochoa Vega | Zendy; C. Montilla | Zendy

Open Access

Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19)

Author(s) -

Jeffrey D. Jenks,

Saima Aslam,

Lucy E. Horton,

Nancy Law,

Ajay Bharti,

Cathy Logan,

Mahnaz Taremi,

Florin Vaida,

Michele Ritter,

Kathleen Bordeaux,

Claudia Guerrero,

Diana Paddock,

Joseph Bautista,

Claudia Medrano,

Sarah Arend,

Mackenzie Williams,

Marvin Ochoa Vega,

C. Montilla

Publication year - 2021

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciab522

Subject(s) - medicine , covid-19 , coronavirus , betacoronavirus , monoclonal antibody , virology , disease , coronavirus infections , pandemic , administration (probate law) , antibody , intensive care medicine , immunology , outbreak , infectious disease (medical specialty) , political science , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research